Alpha Centric Advisors LLC Alkermes Plc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$27.17 - $31.97 $203,775 - $239,775
7,500 Added 21.43%
42,500 $1.19 Million
Q2 2023

Aug 08, 2023
SELL
$28.34 - $33.63 $283,400 - $336,300
-10,000 Reduced 22.22%
35,000 $1.1 Million
Q1 2023

May 12, 2023
BUY
$25.31 - $29.02 $1.14 Million - $1.31 Million
45,000 New
45,000 $1.27 Million

Others Institutions Holding ALKS

# of Institutions
364
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.61B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email